Relief Cardiovascular Revenue and Competitors
Estimated Revenue & Valuation
- Relief Cardiovascular's estimated annual revenue is currently $2.5M per year.
- Relief Cardiovascular's estimated revenue per employee is $226,909
Employee Data
- Relief Cardiovascular has 11 Employees.
- Relief Cardiovascular grew their employee count by 57% last year.
Relief Cardiovascular's People
Name | Title | Email/Phone |
---|---|---|
1 | Principal Electrical Engineer | Reveal Email/Phone |
2 | Sr. Principal R&D Engineer | Reveal Email/Phone |
3 | R&D Technician | Reveal Email/Phone |
4 | Research And Development Engineer | Reveal Email/Phone |
5 | Sr. Principal Engineer | Reveal Email/Phone |
Relief Cardiovascular Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.2M | 27 | 80% | N/A | N/A |
#2 | $0.3M | 8 | -33% | N/A | N/A |
#3 | $1.7M | 68 | 106% | N/A | N/A |
#4 | $4M | 24 | 14% | $26.1M | N/A |
#5 | $1.7M | 4 | 0% | $1.7M | N/A |
#6 | $7.5M | 29 | 21% | N/A | N/A |
#7 | $3.5M | 15 | 0% | $37.9M | N/A |
#8 | $1.1M | 14 | 133% | N/A | N/A |
#9 | $1.1M | 6 | 50% | N/A | N/A |
#10 | $3.4M | 20 | -5% | N/A | N/A |
What Is Relief Cardiovascular?
Relief Cardiovascular, an inQB8 Medical Technologies portfolio company, is creating a novel smart implant to decongest heart failure patients. \n\nThe Relief System is the world’s first transcatheter implant to both monitor and modulate renal vein pressures, offering a novel solution for managing fluid in heart failure patients – particularly for the millions of heart failure patients with diuretic resistance.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.5M
Revenue (est)
57%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | 10% | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1M | 12 | 50% | N/A |
#4 | $1M | 12 | 20% | N/A |
#5 | $0.8M | 13 | 44% | $2.3M |